Artivion (AORT) News Today $28.29 -0.53 (-1.83%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$28.28 -0.01 (-0.05%) As of 02/21/2025 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Artivion (AORT) Projected to Post Quarterly Earnings on ThursdayArtivion (NYSE:AORT) will be releasing earnings before the market opens on Thursday, February 20, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=432809)February 13, 2025 | marketbeat.comArtivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial ResultsFebruary 10, 2025 | prnewswire.comSG Americas Securities LLC Sells 9,689 Shares of Artivion, Inc. (NYSE:AORT)SG Americas Securities LLC lowered its stake in Artivion, Inc. (NYSE:AORT - Free Report) by 57.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,197 shares of the company's stock after selling 9,689 shares during the period. SG Americas SecuriFebruary 8, 2025 | marketbeat.comArtivion, Inc. (NYSE:AORT) Shares Purchased by Calamos Advisors LLCCalamos Advisors LLC raised its holdings in Artivion, Inc. (NYSE:AORT - Free Report) by 113.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 63,029 shares of the company's stock after buying an additional 33,541 shares during the quarter.February 5, 2025 | marketbeat.comArtivion, Inc. (AORT) Stock ForecastsJanuary 31, 2025 | ca.finance.yahoo.comPositive Trial Data and FDA Prospects Drive Buy Rating for ArtivionJanuary 28, 2025 | markets.businessinsider.comArtivion Receives Buy Rating from Michael Matson Following Promising Clinical Trial Results and Market Expansion OpportunitiesJanuary 28, 2025 | markets.businessinsider.comArtivion's (AORT) Buy Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and issued a $34.00 price objective on shares of Artivion in a research note on Tuesday.January 28, 2025 | marketbeat.comOppenheimer maintains Artivion stock with $32 targetJanuary 28, 2025 | msn.comArtivion presents data on AMDS in DeBakey aortic dissectionsJanuary 28, 2025 | markets.businessinsider.comOppenheimer maintains Artivion Outperform with $32 targetJanuary 28, 2025 | msn.comArtivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual MeetingJanuary 27, 2025 | prnewswire.comJPMorgan Chase & Co. Has $2.61 Million Stock Holdings in Artivion, Inc. (NYSE:AORT)JPMorgan Chase & Co. raised its stake in Artivion, Inc. (NYSE:AORT - Free Report) by 394.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,903 shares of the company's stock after buying aJanuary 21, 2025 | marketbeat.comIs Artivion, Inc. (AORT) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?January 20, 2025 | insidermonkey.comArtivion (NYSE:AORT) Reaches New 1-Year High - Here's WhyArtivion (NYSE:AORT) Reaches New 12-Month High - Here's What HappenedJanuary 16, 2025 | marketbeat.comArtivion (AORT) Gets a Buy from Lake StreetJanuary 7, 2025 | markets.businessinsider.comBarclays PLC Purchases 54,996 Shares of Artivion, Inc. (NYSE:AORT)Barclays PLC raised its holdings in Artivion, Inc. (NYSE:AORT - Free Report) by 346.3% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 70,877 shares of the company's stock after acquiring an additional 54,996 shares during the quarter. Barclays PLDecember 27, 2024 | marketbeat.comJane Street Group LLC Purchases 24,945 Shares of Artivion, Inc. (NYSE:AORT)Jane Street Group LLC increased its holdings in Artivion, Inc. (NYSE:AORT - Free Report) by 69.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 61,035 shares of the company's stock after acquiring an adDecember 27, 2024 | marketbeat.comArtivion: Current Valuation Seems StretchedDecember 26, 2024 | seekingalpha.com217,800 Shares in Artivion, Inc. (NYSE:AORT) Bought by Lord Abbett & CO. LLCLord Abbett & CO. LLC bought a new stake in shares of Artivion, Inc. (NYSE:AORT - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 217,800 shares of the company's stock, valued at approximately $5,798,000. LoDecember 17, 2024 | marketbeat.comFmr LLC Has $3.07 Million Holdings in Artivion, Inc. (NYSE:AORT)Fmr LLC increased its stake in shares of Artivion, Inc. (NYSE:AORT - Free Report) by 28.0% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 115,184 shares of the company's stock after acquiring an additional 25,176 shares during the period. FDecember 15, 2024 | marketbeat.comTidal Investments LLC Has $4.18 Million Holdings in Artivion, Inc. (NYSE:AORT)Tidal Investments LLC lifted its holdings in shares of Artivion, Inc. (NYSE:AORT - Free Report) by 602.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 157,002 shares of the company's stock after purchasing an additionalDecember 14, 2024 | marketbeat.comJean F. Holloway Sells 8,070 Shares of Artivion, Inc. (NYSE:AORT) StockDecember 13, 2024 | insidertrades.comArtivion, Inc. (NYSE:AORT) Holdings Lifted by Wellington Management Group LLPWellington Management Group LLP boosted its holdings in Artivion, Inc. (NYSE:AORT - Free Report) by 2.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,656,264 shares of the company's stDecember 12, 2024 | marketbeat.comBNP Paribas Financial Markets Increases Stock Position in Artivion, Inc. (NYSE:AORT)BNP Paribas Financial Markets raised its stake in Artivion, Inc. (NYSE:AORT - Free Report) by 543.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 28,574 shares of the company's stock after acquiringDecember 12, 2024 | marketbeat.comArtivion: FDA grants HDE for use of AMDS Hybrid ProsthesisDecember 11, 2024 | markets.businessinsider.comArtivion, Inc. (NYSE:AORT) CAO Amy Horton Sells 4,329 SharesDecember 10, 2024 | insidertrades.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Artivion (AORT) and Revance Therapeutics (RVNC)December 9, 2024 | markets.businessinsider.comArtivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid ProsthesisDecember 9, 2024 | prnewswire.comArtivion, Inc. (NYSE:AORT) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Artivion, Inc. (NYSE:AORT - Free Report) by 58.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor ownedDecember 9, 2024 | marketbeat.comCentiva Capital LP Takes Position in Artivion, Inc. (NYSE:AORT)Centiva Capital LP acquired a new position in shares of Artivion, Inc. (NYSE:AORT - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 21,237 shares of the company's stock, valued at approximatelyDecember 8, 2024 | marketbeat.com36,046 Shares in Artivion, Inc. (NYSE:AORT) Acquired by Walleye Capital LLCWalleye Capital LLC purchased a new position in shares of Artivion, Inc. (NYSE:AORT - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 36,046 shares of the company's stock, valued at approximately $December 7, 2024 | marketbeat.comArtivion, Inc. (NYSE:AORT) VP Sells $228,540.00 in StockDecember 5, 2024 | insidertrades.comArtivion, Inc. (NYSE:AORT) Sees Large Increase in Short InterestArtivion, Inc. (NYSE:AORT - Get Free Report) was the target of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 3,220,000 shares, a growth of 7.3% from the October 31st total of 3,000,000 shares. Currently, 8.2% of the company's shares are sold short. Based on an average daily volume of 223,200 shares, the days-to-cover ratio is currently 14.4 days.December 3, 2024 | marketbeat.comWasatch Advisors LP Sells 105,717 Shares of Artivion, Inc. (NYSE:AORT)Wasatch Advisors LP trimmed its holdings in shares of Artivion, Inc. (NYSE:AORT - Free Report) by 11.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 815,832 shares of the company's stock after selling 105,717 shares durDecember 1, 2024 | marketbeat.comReturns On Capital Are Showing Encouraging Signs At Artivion (NYSE:AORT)November 30, 2024 | finance.yahoo.comSio Capital Management LLC Takes Position in Artivion, Inc. (NYSE:AORT)Sio Capital Management LLC purchased a new position in shares of Artivion, Inc. (NYSE:AORT - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 121,178 shares of the company's stock, valuedNovember 29, 2024 | marketbeat.comQuest Partners LLC Has $661,000 Position in Artivion, Inc. (NYSE:AORT)Quest Partners LLC raised its holdings in shares of Artivion, Inc. (NYSE:AORT - Free Report) by 2,481,700.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,818 shares of the company's stock after purchasing an additioNovember 23, 2024 | marketbeat.comArtivion, Inc. (NYSE:AORT) Shares Sold by Royce & Associates LPRoyce & Associates LP lessened its holdings in shares of Artivion, Inc. (NYSE:AORT - Free Report) by 13.3% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 871,170 shares of the company's stock after selling 133,210 shares during the peNovember 16, 2024 | marketbeat.comArtivion, Inc. (AORT) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comArtivion Inc (AORT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic AdvancesNovember 9, 2024 | finance.yahoo.comArtivion price target raised to $32 from $29.60 at LadenburgNovember 9, 2024 | markets.businessinsider.comArtivion (AORT) Gets a Buy from OppenheimerNovember 9, 2024 | markets.businessinsider.comWhere Artivion Stands With AnalystsNovember 8, 2024 | benzinga.comArtivion (NYSE:AORT) Price Target Raised to $32.00 at OppenheimerOppenheimer increased their target price on shares of Artivion from $30.00 to $32.00 and gave the stock an "outperform" rating in a research report on Friday.November 8, 2024 | marketbeat.comArtivion’s Q3 2024: Revenue Growth and Strategic ProgressNovember 8, 2024 | markets.businessinsider.comArtivion’s Strong Financial Performance and Strategic Growth Opportunities Drive Buy RatingNovember 8, 2024 | markets.businessinsider.comArtivion reports Q3 non-GAAP EPS 12c, consensus (6c)November 8, 2024 | markets.businessinsider.comArtivion narrows 2024 revenue view to $389M-$396M from $388M-$396MNovember 8, 2024 | markets.businessinsider.comArtivion Reports Third Quarter 2024 Financial ResultsNovember 7, 2024 | prnewswire.com Get Artivion News Delivered to You Automatically Sign up to receive the latest news and ratings for AORT and its competitors with MarketBeat's FREE daily newsletter. Email Address AORT Media Mentions By Week AORT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AORT News Sentiment▼0.000.60▲Average Medical News Sentiment AORT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AORT Articles This Week▼02▲AORT Articles Average Week Get Artivion News Delivered to You Automatically Sign up to receive the latest news and ratings for AORT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Inari Medical News Today Envista News Today PROCEPT BioRobotics News Today iRhythm Technologies News Today Warby Parker News Today LivaNova News Today Enovis News Today TransMedics Group News Today NovoCure News Today Tandem Diabetes Care News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AORT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artivion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artivion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AORT Stock Alerts